Biotech · Private company · Gainesville, FL, US

Serodopa Therapeutics Inc

Track this companyFree. Adds Serodopa Therapeutics Inc to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards2

NX90: A Treatment for Overdose Caused by High Potency OpioidsFiscal year 2025 · $1.4MNIH RePORTER 5R44DA061722-02 · fetched Nov 12, 2026
NX90: A Treatment for Overdose Caused by High Potency OpioidsFiscal year 2024 · $1.5MNIH RePORTER 1R44DA061722-01 · fetched Nov 12, 2026